Searchable abstracts of presentations at key conferences in endocrinology

ea0015p164 | Endocrine tumours and neoplasia | SFEBES2008

Unsteady amenorrhoea

Pusalkar Pawan , Nussey S , Bano G

A 26-year-old Caucasian female presented with nausea, intermittent abdominal pain and amenorrhoea of 3 months duration. She was known to have Von Hippel–Lindau disease (Exon 3A/T 742 mutation) and had undergone surgery for cerebellar haemangioblastoma. She also had presumed dermoid cyst in right ovary which had been monitored by ultrasound. Ultrasound revealed an increase in size and vascularity of right ovarian cyst. MRI scan revealed it to be a 6.3 cm lobulated mass in ...

ea0015p350 | Thyroid | SFEBES2008

Does cord blood selenium correlate with maternal anti-TPO-titers?

Pflanz Benita , Peters Norbert , Bohnet Heinz G

Selenium (Se) has been shown to capture radicals, one of which is oxygen originating from thyroxin-peroxidase (TPO) activity. Se supplementation to patients with Hashimoto’s resulted in a decrease of anti-TPO-titers and Se concentrations of ≥1.4 μmol/l have been proven to prevent deterioration of post partum thyreoiditis. Our group previously showed that in nonpregnant women with Hashimoto’s Se concentrations were decreased, and pregnant women have decreas...

ea0014p388 | (1) | ECE2007

Characteristics of locally advanced differentiated thyroid cancer in &br;a cohort of patients surgically treated at one oncological institution

Baldelli R , Pasimeni G , Barnabei A , Appetecchia M

Differentiated thyroid carcinomas (DTC) (papillary, follicular and follicular type of papillary) are characterized by a favourable prognosis, but a part of patients can develop recurrences and eventually die of the disease. We retrospectively reviewed 108 DTC patients affected by locally advanced thyroid carcinoma (77 females, 31 males) (49±15 years), in order to evaluate validate known prognostic factors that enable them to be recognised as having a low or a high risk of...

ea0013p107 | Clinical practice/governance and case reports | SFEBES2007

Double Y syndrome as a cause of gynaecomastia

Sharfi MO , Nussey SS , Bano G

A 68 year old retired accountant presented with loss of libido, reduced shaving frequency, obesity and gynaecomastia. His past medical history included osteoarthritis and facial acne. There was no related family history and he was taking no medications. He reported having two children.On examination the BMI was 31.7 kg/m2 and height 181 cm. He was normotensive and bilateral gynaecomastia was noted. He has reduced body hair; testicular volume w...

ea0013p281 | Steroids | SFEBES2007

An adrenal ‘coming full circle’

Zachariah Sunil , Nussey Steve , Bano G

37 year old gentleman presented with Cushing’s disease at the age of 15 with obesity, growth retardation, and vertebral fracture. After bilateral adrenalectomy and pituitary irradiation he was treated with hydrocortisone and fludrocortisone. After being lost to follow up for a number of years he was referred to our endocrine clinic in 1999. Clinical examination revealed that he was obese (BMI 39.2), hypertensive and had marked abdominal striae. Investigations revealed an ...

ea0012oc6 | Young Endocrinologist prize session | SFE2006

Subcellular distribution of thyroglobulin (Tg) and sodium-iodine-symporter (NIS) in normal thyroid, Graves’ and thyroid carcinomas using confocal microscopy

Kollecker I , von Wasielewski R , Brabant G

NIS and Tg are viewed as characteristic markers for thyrocytes. They are still expressed in a high percentage of differentiated and undifferentiated thyroid carcinomas but these data are obtained by conventional immunohistochemistry. Here we used tissue microarrays and confocal microscopy to compare subcellular localization of Tg and NIS in a large series of benign and malignant thyroid samples.Methods157 papillary (PTC), 56 follic...

ea0012p82 | Pituitary | SFE2006

Combined pituitary hormone deficiency secondary to suspected PIT-1 mutation

Haq M , Bano G , Nussey S

A 30 year-old man was assessed for gynaecomastia. He had been treated for GH deficiency from the age of 3 to 16. His non-consanguineous parents were of short stature (maternal height 1.22 m, paternal height 1.58 m), as was a half-sister (1.55 m). The patient’s height was 1.55 m with an arm span of 1.48 m and his BMI was 31. Testicular volume was 18 mL and secondary sexual characteristics were normally developed. Lipomastia was diagnosed and subsequently treated surgically...

ea0012p86 | Pituitary | SFE2006

Growth hormone deficiency and complex congenital abnormalities: a further case of Stratton-Parker syndrome?

Simmgen M , Bano G , Nussey S

A 23 year-old male was assessed for recommencement of growth hormone replacement therapy. He had discontinued treatment a year ago but not experienced any adverse symptoms since.The patient had been born with multiple congenital malformations. Midline defects included oesophageal atresia, imperforate anus and partial sacral agenesis. Urogenital abnormalities required a left nephro-ureterectomy soon after birth and an orchidopexy was performed at the age ...

ea0012p134 | Thyroid | SFE2006

MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) and thyrotoxicosis

Caputo C , Devendra D , Williams G , Dornhurst A

A 26-year-old woman presented with vomiting and cortical blindness. CT scan of the brain confirmed a right-sided parietal-occipital infarct, She subsequently developed seizures and neurological extension resulting in global dysphasia. Serum and CSF lactate were elevated (4.4 and 4.3 mmol/l respectively, NR<1.8). MELAS syndrome was confirmed by mitochondrial DNA analysis, which revealed an A3243G mutation in muscle and serum (85% muscle, 63% urinary epithelial cells and 33%...

ea0011s34 | Clinical lessons from novel aspects of G protein-coupled receptors signalling | ECE2006

How the pattern of GPCR co-expression can regulate function

Milligan G , Pediani J , Ellis J

The pharmacology and function of G protein-coupled receptors (GPCRs) is frequently studied following expression of a single receptor in heterologous cell lines. However, many GPCRs are co-expressed. We wished to investigate how expression of pairs of receptors might modulate their function. Using a Human Embryonic Kidney 293 cell line in which the CB1 cannabinoid receptor was expressed constitutively and in which varying levels of expression of the orexin-1 receptor could be i...